These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29098384)

  • 41. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
    Poultsides GA; Bao F; Servais EL; Hernandez-Boussard T; DeMatteo RP; Allen PJ; Fong Y; Kemeny NE; Saltz LB; Klimstra DS; Jarnagin WR; Shia J; D'Angelica MI
    Ann Surg Oncol; 2012 Sep; 19(9):2797-804. PubMed ID: 22476753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective resection of colorectal liver metastases.
    Tamandl D; Gruenberger B; Herberger B; Schoppmann S; Bodingbauer M; Schindl M; Puhalla H; Fleischmann E; Schima W; Jakesz R; Laengle F; Gruenberger T
    Eur J Surg Oncol; 2007 Mar; 33(2):174-82. PubMed ID: 17046194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases.
    Pulitanò C; Arru M; Catena M; Guzzetti E; Vitali G; Ronzoni M; Venturini M; Villa E; Ferla G; Aldrighetti L
    Ann Surg Oncol; 2008 Jun; 15(6):1661-9. PubMed ID: 18373123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study.
    Kataoka K; Kanazawa A; Nakajima A; Yamaguchi A; Arimoto A; Kohno Y
    Surg Today; 2013 Oct; 43(10):1154-61. PubMed ID: 23139049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colorectal liver metastases: hepatic pedicle clamping during hepatectomy reduces the incidence of tumor recurrence in selected patients. Case-matched analysis.
    De Carlis L; Di Sandro S; Giacomoni A; Mihaylov P; Lauterio A; Mangoni I; Cusumano C; Poli C; Tripepi M; Bencardino K
    Eur J Surg Oncol; 2013 Jul; 39(7):726-33. PubMed ID: 23601983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective analysis of clinical and pathologic risk factors in liver resection for hepatic colorectal metastases.
    Zhou L; Zhag G; Tang T; Lian R; Wang W
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S178-82. PubMed ID: 24516057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
    Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
    Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
    Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW
    J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.
    Mao R; Zhao JJ; Bi XY; Zhang YF; Li ZY; Zhou JG; Zhao H; Cai JQ
    Int J Surg; 2018 May; 53():371-377. PubMed ID: 29229309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.
    Nishioka Y; Paez-Arango N; Boettcher FO; Kawaguchi Y; Newhook TE; Chun YS; Tzeng CD; Tran Cao HS; Lee JE; Vreeland TJ; Vauthey JN
    J Gastrointest Surg; 2022 Apr; 26(4):791-801. PubMed ID: 34725784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver resection for gastric cancer metastases.
    Viganò L; Vellone M; Ferrero A; Giuliante F; Nuzzo G; Capussotti L
    Hepatogastroenterology; 2013 May; 60(123):557-62. PubMed ID: 23635434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.
    Kato T; Yasui K; Hirai T; Kanemitsu Y; Mori T; Sugihara K; Mochizuki H; Yamamoto J
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S22-31. PubMed ID: 14530655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome after repeat resection of liver metastases from colorectal cancer.
    Neeff HP; Drognitz O; Holzner P; Klock A; Bronsert P; Hopt UT; Makowiec F
    Int J Colorectal Dis; 2013 Aug; 28(8):1135-41. PubMed ID: 23468250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Favorable outcome after repeat resection for colorectal liver metastases.
    Saiura A; Yamamoto J; Koga R; Takahashi Y; Takahashi M; Inoue Y; Ono Y; Kokudo N
    Ann Surg Oncol; 2014 Dec; 21(13):4293-9. PubMed ID: 24962942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
    Sadot E; Groot Koerkamp B; Leal JN; Shia J; Gonen M; Allen PJ; DeMatteo RP; Kingham TP; Kemeny N; Blumgart LH; Jarnagin WR; DʼAngelica MI
    Ann Surg; 2015 Sep; 262(3):476-85; discussion 483-5. PubMed ID: 26258316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.